Skip to content
Markets News
Stocks1 min read

Challenger Rejects Daiichi Life Unit’s A$11.80 Bid

Makkler Newsroom
October 26, 2026 · Based on reporting by The Japan Times, Nikkei Asia

Challenger turned down the indicative offer for its remaining shares but said it would continue discussions with Daiichi Life’s Australian unit.

Key takeaways

  • Challenger rejected an indicative A$11.80-per-share offer for its remaining 79.5%.
  • The board said it would engage with TAL Daiichi Life Australia, with no certainty of a binding offer.

Challenger’s board rejected an indicative takeover offer of A$11.80 per share from TAL Daiichi Life Australia for the remaining 79.5% of the company. It said it would engage with the Japanese insurer’s Australian unit to see whether a proposal could be reached that the board would recommend to shareholders.

Challenger said the bid was not at a level it could recommend and that there was no certainty a binding offer or transaction would result.

Bloomberg Intelligence analyst Matt Ingram said Challenger’s sum-of-the-parts value was above the bid. He wrote that a revised offer of A$12.50 to A$13 per share might be more acceptable to the board.

As of 5:20 a.m. UTC Monday, Challenger shares traded at A$11.85, down 0.59% since the previous close. Daiichi Life shares were at ¥1,830.5, up 0.63% as of 6:30 a.m. UTC.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.